Subscribe

Subscribe

Latest Content

Solar

Storage

Wind

Event Spotlight

BLOGS

DISTRIBUTECH+ RECAP: Energy Storage Utility Case Studies

Webcast

OPINION

RESOURCES

CLARION ENERGY MEDIA

POWER & ENERGY EVENT SERIES

Privacy Policy

Copyright © 2019 - 2021

Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

67.71 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 766
Open 67.71
Bid (Size) 67.65 (4)
Ask (Size) 67.70 (1)
Prev. Close 67.71
Today's Range 67.71 - 67.71
52wk Range 64.41 - 83.25
Shares Outstanding 1,319,574,744
Dividend Yield 3.57%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unpacking the Latest Options Trading Trends in CVS Health
Via Benzinga
Walmart Pulls Plug On Health Centers, Telehealth; Respite For TDOC?
Walmart is shutting down its health centers and virtual care offering, continuing a broader shakeup in telehealth. WMT stock is near a buy point. 
Via Investor's Business Daily

Performance

YTD
-16.25%
-16.25%
1 Month
-14.89%
-14.89%
3 Month
-8.31%
-8.31%
6 Month
-1.88%
-1.88%
1 Year
-8.36%
-8.36%

More News

Read More
AbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales
Via Investor's Business Daily
DoorDash: 5 Compelling Reasons to Buy the Dip
Via MarketBeat
Topics Death
Exposures Death
3 Value Stocks to Buy on the Dip: April 2024
Via InvestorPlace
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Via Benzinga
Topics Stocks
Exposures US Equities
Is This Beaten-Down Dividend Stock a Buy?
Via The Motley Fool
Looking Into CVS Health's Recent Short Interest
Via Benzinga
Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost
Via Benzinga
5 High-Yielding Oversold Stocks with Bullish Ratings
Via MarketBeat
Topics Economy
Exposures Interest Rates
7 blue chip stocks to Buy on the Dip: April 2024
Via InvestorPlace
3 Absurdly Cheap Stocks to Buy and Hold for Years
Via The Motley Fool
Put $5,000 in These 7 Blue-Chip Stocks Today
Via InvestorPlace
Analyst Ratings For CVS Health
Via Benzinga
Beat the Dow Jones With This Cash-Gushing Dividend Stock
Via The Motley Fool
Topics Stocks
Exposures US Equities
The Smartest Dividend Stocks to Buy With $400 Right Now
Via The Motley Fool
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
Via Investor's Business Daily
Freeport-McMoRan, AppLovin And A Major Healthcare Stock On CNBC's 'Final Trades'
Via Benzinga
3 Defensive Stocks to Buy for Increased Volatility in April
Via InvestorPlace
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
Via InvestorPlace
Topics ETFs
See How Florida's Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, Molina
Via Benzinga
Girl Power Portfolio: 3 High-Potential Stocks With Women CEOs to Buy Now
Via InvestorPlace
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
Via InvestorPlace
CVS Health's Zero-Cost Coverage Paves Way For OTC Birth Control Access
Via Benzinga
Market Rally Under Pressure; Tesla, Humana In Focus: Weekly Review
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.